Immunotherapy is the brightest new weapon in fight against cancer. Thank Dr. Steven Rosenberg, who 40 years ago successfully used it to save a life.

Novartis NVS announced that the European Commission (“EC”) has approved its breast cancer drug Kisqali (ribociclib) for a ...

A phase 2 study for patients with HR-positive, HER2-negative metastatic breast cancer will be evaluating alisertib plus ...

Dr. Reddys has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab, already approved by USFDA and EMA, will ...

Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...

The Duchess of York was diagnosed with a malignant melanoma, a form of skin cancer, in January this year. She says undergoing ...

Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in ...

Previously, NMPA has accepted two supplemental new drug applications (sNDA) seeking the approvals of sac-TMT monotherapy for the treatment of patients with locally advanced or metastatic EGFR-mutant ...

Cancer metabolism is a critical area of research, central to understanding how malignant tumors manipulate metabolic pathways to support their growth and survival. These alterations not only fuel ...

The Duchess of York revealed she was diagnosed with a form of skin cancer earlier this year. It was discovered as she ...

Get Anti-cancer drug Toripalimab News on Telangana Today, Anti-cancer drug Toripalimab latest news, Anti-cancer drug Toripalimab news, | Telangana Today ...

The drug is the only immuno-oncology drug approved by various regulatory authorities around the world for the treatment of ...